Antibe Therapeutics Inc. announced that Walt Macnee has been appointed as Chairman of the Board of Directors of the Corporation to replace John Wallace, who will continue to serve as a director and Chief Science Officer. Mr. Macnee's appointment was made to ensure that the Chairman position is occupied by an independent director. Antibe thanks Dr. Wallace for his past services as Chairman.